William Stewart and the ISV-205 Study Group are to be congratulated on their innovative approach to preventing and perhaps treating steroid-induced glaucoma using topical diclofenac sodium.1 Could we seek a few clarifications?
What was the basis for selecting a sample size of 136 volunteers? What difference in intraocular pressure was predetermined to be clinically significant to arrive at this sample size?